Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.1.18 (
branching enzyme
)
628
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Starch is the largest component of the wheat (
Triticum aestivum
L.) grain and consists of approximately 70-80% amylopectin and 20-30% amylose. Amylopectin is a highly-branched, readily digested polysaccharide, whereas amylose has few branches and forms complexes that resist digestion and mimic dietary fiber (resistant starch). Down-regulation of the
starch branching enzyme
II
(
SBEII
) gene by RNA interference (RNAi) was previously shown to increase amylose content in both hexaploid and tetraploid wheat. We generated ethyl
methane
sulphonate (EMS) mutants for the
SBEIIa
-A and
SBEIIa
-B homoeologs in the tetraploid durum wheat variety Kronos (
T. turgidum
ssp.
durum
L.). Single-gene mutants showed non-significant increases in amylose and resistant starch content, but a double mutant combining a
SBEIIa
-A knock-out mutation with a
SBEIIa
-B splice-site mutation showed a 22% increase in amylose content (
P
<0.0001) and a 115% increase in resistant starch content (
P
<0.0001). In addition, we obtained mutants for the A and B genome copies of the paralogous
SBEIIb
gene, mapped them 1-2 cM from
SBEIIa
, and generated double
SBEIIa-SBEIIb
mutants to study the effect of the
SBEIIb
gene in the absence of
SBEIIa
. These mutants are available to those interested in increasing amylose content and resistant starch in durum wheat.
...
PMID:Induced mutations in the
starch branching enzyme II
(
SBEII
) genes increase amylose and resistant starch content in durum wheat. 2692 49